Streetbeat News

Stock Prices

NGNE

Neurogene shares surged following the announcement of an expansion and accelerated patient enrollment for its Rett syndrome gene therapy clinical trial.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 5:02 pm

SOPH

Sophia Genetics (NASDAQ:SOPH) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $-0.26. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Despite beating the EPS estimate last quarter, SOPH's share price did not increase the following day. Historically, the company's earnings performance has shown mixed results on its stock price. Currently, SOPH shares are trading at $4.84, reflecting a 99.6% increase over the last 52 weeks, indicating a positive sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:02 pm

CGEN

Compugen (NASDAQ:CGEN) is scheduled to release its quarterly earnings report on 2024-03-05, with analysts expecting an EPS of $0.22. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares have risen 243.79% over the last 52 weeks, indicating a positive long-term outlook. Investors will be keen on both the earnings outcome and the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

CXDO

Crexendo (NASDAQ:CXDO) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $0.04. Historically, the company has surpassed EPS estimates, leading to significant stock price movements. Last quarter, Crexendo beat the EPS estimate by $0.10, resulting in a 9.71% share price increase the following day. Over the past year, CXDO shares have surged by 196.13%, indicating strong investor confidence ahead of the upcoming earnings announcement.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

AEVA

Aeva Technologies (NYSE:AEVA) is expected to report a Q4 earnings per share (EPS) of $-0.15 on March 5, 2024. Historically, the company has beaten EPS estimates but experienced share price drops post-earnings. Over the last year, AEVA shares have declined by 38.61%, with the stock currently trading at $1.03. Investors are looking for not just an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

LXU

LSB Industries (NYSE:LXU) is scheduled to release its quarterly earnings report on 2024-03-05, with analysts estimating an EPS of $0.04. The company's past earnings performance shows mixed results, with the last quarter beating estimates by $0.02 but resulting in a 2.18% share price drop the following day. Over the last year, LXU shares have declined by 44.91%, indicating potential investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

FLL

Full House Resorts (NASDAQ:FLL) is scheduled to release its quarterly earnings report on March 5, 2024, with an estimated EPS of $-0.14. Historical data shows a pattern of stock price movement post-earnings announcement, with a notable 18.67% increase after last quarter's beat. Over the past year, FLL shares have declined by 47.63%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

UBER

Uber Technologies (NYSE:UBER) has seen a diverse range of analyst ratings over the last three months, with a total of 34 analysts offering perspectives. The sentiment has shifted positively, with the average 12-month price target rising to $80.65, up 14.69% from $70.32. Analysts have predominantly raised their ratings and price targets, reflecting optimism about Uber's market position, revenue growth, and financial health. Uber's market capitalization, revenue growth, net margin, ROE, ROA, and debt management are highlighted as indicators of its strong performance.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares fell over 6% due to a decline in February China sales, with a reported 18.87% decrease year-over-year and a 15.51% decrease from January. The company has initiated a trade-in promotion in the U.S. to boost Q1 sales. Tesla's long-term outlook considers the impact of interest rates on growth stocks and its historical revenue growth rate of 42.28% annually over the past 5 years. Tesla's forward P/E of 64.94 categorizes it as a growth stock.

Portfolio Pulse from Erica Kollmann

March 04, 2024 | 5:01 pm

NPCE

NeuroPace (NASDAQ:NPCE) is scheduled to release its quarterly earnings report on 2024-03-05, with analysts expecting an EPS of $-0.31. The company's past performance shows a mixed reaction to earnings reports, with the last quarter beating estimates but resulting in a 1.81% drop in share price the next day. Shares have risen 250.34% over the last 52 weeks, indicating a positive long-term outlook among shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:01 pm